Get the Daily Brief
Latest Biotech News
Innovative Immunotherapy Shows Systemic Impact in Metastatic Cancer
A Phase I clinical trial of an Fc-engineered CD40 agonist antibody (2141.V11), administered intratumorally, demonstrated remarkable systemic antitumor efficacy in metastatic cancer patients. Among...
Breakthrough Imaging Captures First Real-Time Human Embryo Implantation
Scientists at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have captured the first real-time, three-dimensional recordings of human embryo implantation. Using a...
Biopharma Raises Funding Amid Record Deal Activity and IPO Drought
Biopharma dealmaking excluding mergers and acquisitions surged to $164 billion in the first seven months of 2025, marking a 36% increase over 2024, driven by several blockbuster collaborations and...
Eli Lilly Raises Drug Prices in Europe to Offset US Costs
Pharmaceutical company Eli Lilly announced plans to substantially increase prices for its weight-loss drug Mounjaro and other drugs in European markets, including a 170% hike for Mounjaro's...
Advances in AI and Machine Learning Transform Drug Development
Recent studies highlight the transformative impact of artificial intelligence (AI) across drug discovery and biological data generation. MIT researchers demonstrated AI-driven design of novel...
Neuroscience Innovations Enable Direct Mind-to-Text Communication
A novel brain-computer interface developed by neuroscientists allows individuals with severe speech impairments to communicate by decoding inner speech directly from motor cortex neural signals....
Breakthrough Nanobody Therapy Targets Lung Cancer Precisely
Researchers at the Korea Research Institute of Bioscience and Biotechnology have developed a pioneering nanobody-based therapy designed for precise targeting of lung cancer tumors. This innovative...
FDA Reinstates Vaccine Safety Task Force Amid Controversy
The U.S. Department of Health and Human Services has revived the disbanded Task Force on Safer Childhood Vaccines following pressure from a lawsuit endorsed by anti-vaccine advocacy groups....
FDA Clears Precigen’s Gene Therapy for Rare Respiratory Disease
The U.S. Food and Drug Administration granted full and expedited approval to Precigen Inc.’s gene therapy Papzimeos for adults with recurrent respiratory papillomatosis (RRP), a rare chronic...
MIT AI Generates Antibiotics Against Drug-Resistant Bacteria
Researchers at MIT and collaborators have developed generative artificial intelligence methods to design novel antibiotic compounds effective against multidrug-resistant pathogens, including...
Eli Lilly’s $1.3B Deal with Superluminal Targets Obesity and Cardiometabolic Diseases
Eli Lilly has entered a significant collaboration with Superluminal Medicines in a deal potentially worth $1.3 billion, including upfront payments, equity investments, development and commercial...
CD40 Agonist Antibody Shows Tumor Eradication in Metastatic Cancer Trial
A first-in-human Phase I clinical trial demonstrated promising efficacy of an Fc-optimized CD40 agonistic antibody (2141.V11) delivered via intratumoral injection in 12 metastatic cancer patients....
Real-Time 3D Imaging Captures Human Embryo Implantation
For the first time, researchers from the Institute for Bioengineering of Catalonia and Dexeus University Hospital have recorded human embryo implantation in real time using 3D microscopy on...
Elysium Develops Longer-Lasting Opioid Overdose Antidote
Elysium Therapeutics is advancing its Synthetic Opioid Overdose Prevention and Reversal (SOOPR) program to address fentanyl rebound, a phenomenon where existing opioid antagonists lose effect...
New Research Elucidates Sex Differences in Acute Kidney Injury
A team of German researchers discovered that estrogen confers protection against acute kidney injury (AKI) by inhibiting ferroptosis—a form of programmed cell death—in renal tubule cells. This...
Bionano Reports Q2 Revenue Decline Amid Strategic Shift
Bionano Genomics reported a 13% revenue decrease in Q2 2025 to $6.7 million, reflecting business restructuring focused on optical genome mapping and Via software routine users. Product sales...
AI Advances Transform Drug Discovery and Structural Biology
Cutting-edge artificial intelligence models are revolutionizing biomedical research, as exemplified by the development of PepMLM, an AI that designs peptide binders without structural data,...
Eli Lilly's Global Pricing Strategy Raises Drug Prices in Europe
Eli Lilly announced plans to significantly increase the prices of its weight-loss drug Mounjaro in the UK and other European markets, in an effort to reduce costs in the United States. The price...
CD40 Agonist Antibody Shows Systemic Tumor Control in Early Trial
A novel Fc-optimized CD40 agonistic antibody demonstrated promising antitumor activity in a Phase I trial involving 12 metastatic cancer patients. Administered via intratumoral injection, the...
Precigen’s Gene Therapy Secures Fast FDA Approval for Rare Disease
Precigen Inc. received swift and full FDA approval for Papzimeos (zopapogene imadenovec), a gene therapy for adults with recurrent respiratory papillomatosis (RRP), a rare disease marked by benign...